Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Reduction of Pressure Pain Sensitivity as Novel Non-pharmacological Therapeutic Approach to Type 2 Diabetes: A Randomized Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. In-vitro Recordings of Neural Magnetic Activity From the Auditory Brainstem Using Color Centers in Diamond: A Simulation Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Impact of a Parastomal Bulge on Quality of Life - A Cross-sectional Study of Patients From the Danish Stoma Database

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mineralocorticoid receptor antagonist improves cardiac structure in Type 2 Diabetes: Data from the MIRAD Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: Autonomic nervous system dysfunction (ANSD) is known to affect glucose metabolism in the mammalian body. Tradition holds that glucose homeostasis is regulated by the peripheral nervous system, and contemporary therapeutic intervention reflects this convention.

Objectives: The present study tested the role of cerebral regulation of ANSD as consequence of novel understanding of glucose metabolism and treatment target in type 2 diabetes (T2D), suggested by the claim that the pressure pain sensitivity (PPS) of the chest bone periosteum may be a measure of cerebral ANSD.

Design: In a randomized controlled trial of 144 patients with T2D, we tested the claim that 6 months of this treatment would reduce PPS and improve peripheral glucose metabolism.

Results: In the active treatment group, mean glycated hemoglobin A1c (HbA1c) declined from 53.8 to 50.5 mmol/mol (intragroup p = 0.001), compared with the change from 53.8 to 53.4 mmol/mol in the control group, with the same level of diabetes treatment but not receiving the active treatment (between group p = 0.036). Mean PPS declined from 76.6 to 56.1 units (p < 0.001) in the active treatment group and from 77.5 to 72.8 units (p = 0.02; between group p < 0.001) in the control group. Changes of PPS and HbA1c were correlated (r = 0.37; p < 0.001).

Conclusion: We conclude that the proposed approach to treatment of T2D is a potential supplement to conventional therapy.

Clinical Trial Registration: www.clinicaltrials.gov (NCT03576430).

OriginalsprogEngelsk
Artikelnummer613858
TidsskriftFrontiers in Neuroscience
Vol/bind15
ISSN1662-4548
DOI
StatusUdgivet - 11 mar. 2021

Bibliografisk note

Funding Information:
This work was supported by the Johan Schrøders Erhvervs-og Familiefond, and Innovation Fund Denmark (Grant Reg. No: 8062-00554B).

Funding Information:
We are thankful to the staff of the Metabolic Ward O4 at Department of Medicine, Endocrine Unit, Herlev and Gentofte Hospital, for their very valuable contribution concerning the practical issues: Louise Holmberg Storck, Ulla Kjaerulff-Hansen, Marianne S?rensen, Helle R. Christensen, and Syela Azemovski; statistician Tobias Wirenfeldt Klausen for performing the statistical analyses. We also thank Christian Erik Ballegaard for research assistance. Funding. This work was supported by the Johan Schr?ders Erhvervs-og Familiefond, and Innovation Fund Denmark (Grant Reg. No: 8062-00554B).

Publisher Copyright:
© Copyright © 2021 Faber, Eldrup, Selmer, Pichat, Hecquet, Watt, Kreiner, Karpatschof, Gyntelberg, Ballegaard and Gjedde.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

ID: 67032981